Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464574010 | Rosiglitazone+metformin 4mg/500mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2470937014 | Rosiglitazone+metformin 4mg/500mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3471188017 | Product containing rosiglitazone 4 mg and metformin 500 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3486687017 | Product containing rosiglitazone 4 mg and metformin 500 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3501885017 | Rosiglitazone 4 mg and metformin 500 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3569838018 | Product containing only rosiglitazone 4 mg and metformin 500 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3569839014 | Product containing only rosiglitazone 4 mg and metformin 500 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682840018 | Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682841019 | Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682842014 | Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2942841000052113 | rosiglitazon 4 mg + metformin 500 mg, tablett | sv | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| 4511021000052114 | metforminhydroklorid 500 milligram och rosiglitazonmaleat 4 milligram, oral tablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Product containing metformin and rosiglitazone (medicinal product) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has active ingredient | Metformin (substance) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has active ingredient | Rosiglitazone (substance) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has active ingredient | Rosiglitazone maleate | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Metformin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has basis of strength substance (attribute) | Rosiglitazone maleate | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | har täljarvärde som visar styrka | 4 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has basis of strength substance (attribute) | Metformin hydrochloride | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | har täljarvärde som visar styrka | 500 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has basis of strength substance (attribute) | Metformin hydrochloride | true | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | har täljarvärde som visar styrka | 500 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has active ingredient | Rosiglitazone maleate | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has basis of strength substance (attribute) | Rosiglitazone maleate | true | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | har täljarvärde som visar styrka | 4 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Product containing metformin and rosiglitazone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has precise active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has precise active ingredient | Rosiglitazone maleate | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Metformin and rosiglitazone only product in oral dose form | true | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has precise active ingredient | Metformin hydrochloride | true | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Has precise active ingredient | Rosiglitazone maleate | true | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Product containing biguanide (product) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Product containing thiazolidinedione (product) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and rosiglitazone maleate 4 mg oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR